Leading 4th generation CAR-T in China

Experience groundbreaking CAR-T cell treatment technology offered by our esteemed partner, Shenzhen Geno-Immune Medical Institute (GIMI). Our pioneering therapy delivers hope even in advanced-stage cancers, achieving exceptional patient outcomes.

Send Request

Transforming Cancer Care with Next-Generation Immunotherapy

Shenzhen Genoimmune Medical Institute (GIMI)

Shenzhen, China

The Shenzhen Geno-Immune Medical Institute (GIMI) stands at the forefront of gene and immune cell therapy, pioneering innovative solutions beyond FDA-approved CAR-T treatments. Led by renowned expert Prof. Lung-Ji Chang, inventor of the widely-adopted lentiviral vector system, GIMI has delivered effective treatments for over 1,000 cancer cases with cutting-edge 4th generation CAR-T technologies.

View clinic

Check video about clinic

What is CAR-T Therapy?

Chimeric Antigen Receptor T-cell therapy (CAR-T) is an advanced immunotherapy technique where a patient’s own immune cells (T-cells) are genetically engineered to target and destroy cancer cells specifically. At GIMI, our patented 4th generation CAR-T (4SCAR) technology represents a leap forward in effectiveness and safety.

Personalized Care

Individual assessment of each patient’s cancer profile.
Customized CAR-T cell design and personalized therapeutic planning.

Advanced Technology

Unique patented 4SCAR-T cells with enhanced safety (“suicide gene” safety switch).
Engineered immune effector cells (EIE), cancer vaccines, and advanced gene therapies.

Proven High Success Rate

Achieves up to 90% response rates in eligible patients.
Remarkable effectiveness even in late-stage and treatment-resistant cancers.

Cost-Effective Treatment

Up to 50% lower cost compared to US and European treatments.
CAR-T therapy priced between $100,000 to $200,000.

Conditions Treated by CAR-T Therapy

Hematological cancers. Acute lymphoblastic leukemia (ALL), lymphomas (B-cell lymphoma, mantle cell lymphoma). Solid tumors. Hepatocellular carcinoma (HCC), gastric cancers, pancreatic cancers, gliomas, ovarian cancers. Autoimmune diseases

Treatment Process Overview

Consultation & Evaluation

Initial medical review by expert oncologists conducted online.

Travel & Treatment

Patient travels to China after successful online evaluation.

CAR-T Preparation

Rapid turnaround of 5-7 days to prepare custom CAR-T cells, followed by infusion and comprehensive inpatient care.

Follow-up & Support

Long-term remote monitoring and supportive care provided.

Eternity Life Tourism is the perfect place to start your journey towards wellness.

The company was created for people who care about their health and choose the best. Our mission is to save lives and protect the health of patients

Our company offers you

High-quality treatments in modern clinics with the latest scientific developments and equipment

Assist with choosing the most convenient country, doctor, and clinic, all perfectly matched to your health care needs

Assistants who are known for their efficient organization and deep professional training, guaranteeing you receive expert support

Frequently asked questions

Our patented 4SCAR incorporates enhanced immune-memory signals, cytokine enhancements, and a unique inducible safety switch (“suicide gene”) which significantly reduces severe side effects.
CAR-T is currently most effective in certain hematological malignancies and selected solid tumors. At GIMI, we offer treatments for a broad range of cancers, many not yet covered by standard FDA-approved CAR-T therapies.
Following initial consultation and medical record review, treatment typically begins within one to two weeks.
CAR-T therapy can cause cytokine release syndrome (CRS) and neurotoxicity (ICANS). However, our advanced 4SCAR technology significantly minimizes these risks, with severe CRS occurring in less than 2% of patients.
Yes. We offer full international patient support including visa assistance, interpreter services, accommodations, transportation, and personalized care coordination.

Get Consultation